The role of proteases in epithelial-to-mesenchymal cell transitions in cancer

被引:0
|
作者
Julia Mitschke
Ulrike C. Burk
Thomas Reinheckel
机构
[1] University of Freiburg,Institute of Molecular Medicine and Cell Research
[2] German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg,BIOSS Centre for Biological Signalling Studies
[3] partner site Freiburg,undefined
[4] University of Freiburg,undefined
来源
关键词
Metalloprotease; Deubiquitinating enzyme; Desumoylating enzyme; Transmembrane serine protease; Cathepsin;
D O I
暂无
中图分类号
学科分类号
摘要
Changing the characteristics of cells from epithelial states to mesenchymal properties is a key process involved in developmental and physiological processes as well as in many diseases with cancer as the most prominent example. Nowadays, a great deal of work and literature concerns the understanding of the process of epithelial-to-mesenchymal transition (EMT) in terms of its molecular regulation and its implications for cancer. Similar statements can certainly be made regarding the investigation of the more than 500 proteases typically encoded by a mammalian genome. Specifically, the impact of proteases on tumor biology has been a long-standing topic of interest. However, although EMT actively regulates expression of many proteases and proteolytic enzymes are clearly involved in survival, division, differentiation, and movements of cells, information on the diverse roles of proteases in EMT has been rarely compiled. Here we aim to conceptually connect the scientific areas of “EMT” and “protease” research by describing how several important classes of proteolytic enzymes are regulated by EMT and how they are involved in initiation and execution of the EMT program. To do so, we briefly introduce the evolving key features of EMT and its regulation followed by discussion of protease involvement in this process.
引用
收藏
页码:431 / 444
页数:13
相关论文
共 50 条
  • [31] The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
    Loret, Nele
    Denys, Hannelore
    Tummers, Philippe
    Berx, Geert
    CANCERS, 2019, 11 (06)
  • [32] The Role of Cancer-Derived Exosomes in Tumorigenicity & Epithelial-to-Mesenchymal Transition
    Blackwell, Robert H.
    Foreman, Kimberly E.
    Gupta, Gopal N.
    CANCERS, 2017, 9 (08)
  • [33] Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
    Zhang, Jing
    ten Dijke, Peter
    Wuhrer, Manfred
    Zhang, Tao
    PROTEIN & CELL, 2021, 12 (02) : 89 - 106
  • [34] Distinct cytosine modification profiles define epithelial-to-mesenchymal cell-state transitions
    Lee, Min Kyung
    Brown, Meredith S.
    Wilkins, Owen M.
    Pattabiraman, Diwakar R.
    Christensen, Brock C.
    EPIGENOMICS, 2022, 14 (09) : 519 - 535
  • [35] The role of epithelial-to-mesenchymal transition in renal fibrosis
    Michael Zeisberg
    Raghu Kalluri
    Journal of Molecular Medicine, 2004, 82 : 175 - 181
  • [36] Proteinuria and Epithelial-to-Mesenchymal Transition: The Role of Complement
    Bagnasco, Serena
    Racusen, Lorraine
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (03): : 459 - 460
  • [37] The Role of Histone Variants in the Epithelial-To-Mesenchymal Transition
    Lone, Imtiaz Nisar
    Sengez, Burcu
    Hamiche, Ali
    Dimitrov, Stefan
    Alotaibi, Hani
    CELLS, 2020, 9 (11) : 1 - 11
  • [38] Stem Cell State and the Epithelial-to-Mesenchymal Transition: Implications for Cancer Therapy
    Donnenberg, Vera S.
    Donnenberg, Albert D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (06): : 603 - 619
  • [39] The role of epithelial-to-mesenchymal transition in renal fibrosis
    Zeisberg, M
    Kalluri, R
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (03): : 175 - 181
  • [40] Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
    Renaud, Stephane
    Guenot, Dominique
    Falcoz, Pierre-Emmanuel
    Massard, Gilbert
    Beau-Faller, Michele
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44